DCC plc (LON:DCC) price target raised to GBX 8,100 by Barclays

Analyst Ratings For DCC plc (LON:DCC)

Story continues below

Today, Barclays raised its price target on DCC plc (LON:DCC) to GBX 8,100 per share.

There are 8 Buy Ratings, 1 Hold Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.

The current consensus rating on DCC plc (LON:DCC) is Buy with a consensus target price of GBX 8,233.22 per share, a potential .

Some recent analyst ratings include

  • 9/27/2018-DCC plc (LON:DCC) had its Buy rating reiterated by Canaccord Genuity with a GBX 8,540 price target
  • 9/7/2018-DCC plc (LON:DCC) had its Outperform rating reiterated by Royal Bank of Canada with a GBX 9,500 price target
  • 8/23/2018-DCC plc (LON:DCC) had its Add rating reiterated by Peel Hunt
  • 7/31/2018-DCC plc (LON:DCC) had its Buy rating reiterated by Berenberg Bank with a GBX 5,700 price target


    About DCC plc (LON:DCC)
    DCC plc provides sales, marketing, and support services worldwide. The company's DCC LPG segment sells and markets liquefied petroleum gas (LPG). This segment serves approximately 0.7 million customers. Its DCC Retail & Oil segment engages in the procurement, sale, marketing, and distribution of LPG; operation of retail petrol stations; and reselling of fuel cards. This segment serves approximately 0.9 million customers. The company's DCC Healthcare segment offers products and services to healthcare providers, and health and beauty brand owners; outsourced contract manufacturing service to the health and beauty sector; nutrition products, such as vitamins and health supplements; and beauty products, including skin care, hair care, bath, and body products. This segment provides generic pharmaceuticals, including solid dose, injectable, and inhaler products across a range of therapy areas, including beta lactam and other antibiotics, respiratory, pain management, hematology, addiction, and emergency medicine; and medical devices and consumables in the areas of wound care, electrodes, diathermy, anaesthesia, endovascular, cardiology and IV access, minimally invasive surgery, and diagnostics. Its DCC Technology segment sells a range of computing products, including tablets, notebooks, and PC's; communications products, such as smartphones, feature phones, accessories, and unified communications; and servers and storage, audio visual products, printers, peripherals, cables and connectors, and consumables, as well as consumer technology products comprising gaming consoles, peripherals and software, wearable technology, consumer electronics, and accessories to retailers, etailers, and resellers. This segment also offers supply chain services. DCC plc was founded in 1976 and is headquartered in Dublin, Ireland.

    Recent Trading Activity for DCC plc (LON:DCC)
    Shares of DCC plc closed the previous trading session at 920,00 up +10,00 0,14 % with 80.95 shares trading hands.

    An ad to help with our costs